Inonu University School of Medicine
Malatya, 44280, Turkey (Türkiye)
NCT Number: NCT01612416
The aim of this study is to examine whether there is a difference in macular ganglion cell complex thickness and retinal nerve fiber layer thickness in early-stage Primary open angle glaucoma and normal tension glaucoma with spectral domain OCT.
Looking for future studies?
Notify Me28 year–72 year
All sexes
Interventional
Not applicable
Malatya, 44280, Turkey (Türkiye)
Glaucoma is a progressive optic neuropathy characterized by gradual degeneration of neuronal tissue in which retinal ganglion cells (RGCs) are injured, leading to the loss of the visual field.Recent studies have separately demonstrated a reduction in the macular retinal thickness and in the retinal nerve fibers in both POAG and NTG.It has been demonstrated that in early stage NTG macular GCC thickness showed a strong correlation with thickness of the RNFL. However there have yet to be any reports regarding the comparison of macular thickness, ganglion cell complex and retinal nerve fiber layer between POAG and NTG with RS-3000 RetinaScan at early stage.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
The POAG group inclusion criteria were;
NTG group were included if;
The control group
Exclusion criteria
Ganglion cell, retinal nerve fiber layer and retinal thickness measurements of normal subjects, primary open angle glaucoma and normal tension glaucoma patients using RS-3000 OCT RetinaScan
Other names: GCC and RNFL in Open Angle and Normal Tension Glaucoma.
Time frame: 1 year
Inonu University
Other
Comparison of Ganglion Cell and Retinal Nerve Fiber Layer Thickness in Primary Open Angle Glaucoma and Normal Tension Glaucoma With Spectral Domain OCT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06689696
Eye Diseases, GLAUCOMA 1, OPEN ANGLE, D (Disorder)
Fullerton, California, United States
View Trial DetailsNCT07359547
Eye Diseases, GLAUCOMA 1, OPEN ANGLE, D (Disorder)
Leuven, Vlaams-brabant, Belgium
View Trial DetailsNCT07496957
Eye Diseases, GLAUCOMA 1, OPEN ANGLE, D (Disorder)
Bialystok, Polska, Poland
View Trial DetailsNCT07436871
Cataract, Eye Diseases
View Trial Details